Questões de Concurso Público Prefeitura de Barra Bonita - SC 2026 para Professor II (Língua Estrangeira – Inglês)
Foram encontradas 12 questões
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392978
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
The article uses phrasal and prepositional expressions as
well as discourse markers to establish relationships
between ideas and avoid overly literal interpretation of
individual words.
Judge the statements below as True (T) or False (F):
(__)In "From this, Dr. Horvath developed the 'epigenetic clock'", From this establishes a relationship between the preceding finding and the subsequent development.
(__)In "For instance, the liver ages faster than other organs", For instance introduces a specific example supporting the preceding general statement.
(__)In "Along with serving as a professor", Along with establishes a contrast between Dr. Horvath's academic position and his other institutional role.
(__)In "the project [...] drew on collaborators across UCLA", drew on means that the project made use of the expertise or contribution of those collaborators.
The correct sequence, from top to bottom, is:
Judge the statements below as True (T) or False (F):
(__)In "From this, Dr. Horvath developed the 'epigenetic clock'", From this establishes a relationship between the preceding finding and the subsequent development.
(__)In "For instance, the liver ages faster than other organs", For instance introduces a specific example supporting the preceding general statement.
(__)In "Along with serving as a professor", Along with establishes a contrast between Dr. Horvath's academic position and his other institutional role.
(__)In "the project [...] drew on collaborators across UCLA", drew on means that the project made use of the expertise or contribution of those collaborators.
The correct sequence, from top to bottom, is:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392979
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
The article uses reference chains to connect research
tools, studies and conclusions across sentences.
Consider the following passage:
"Dr. Horvath's epigenetic clocks have become standard tools across aging research [...]. They have been applied in the randomized DO-HEALTH trial [...] and in the Women's Health Initiative [...]. This kind of population-level application aligns closely with the Division of Geriatrics' emphasis on healthy, independent life expectancy."
Considering textual cohesion, select the correct alternative.
"Dr. Horvath's epigenetic clocks have become standard tools across aging research [...]. They have been applied in the randomized DO-HEALTH trial [...] and in the Women's Health Initiative [...]. This kind of population-level application aligns closely with the Division of Geriatrics' emphasis on healthy, independent life expectancy."
Considering textual cohesion, select the correct alternative.
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392982
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
A public-school English teacher uses the UCLA Health
article to assess whether students can distinguish
established findings from hypotheses and emerging
possibilities. Such distinctions depend on close reading
of lexical choices that indicate different degrees of
certainty.
Based on the text, judge the statements below as True (T) or False (F):
(__)The epigenetic clock is presented as one useful measure of biological aging rather than as a complete explanation of longevity.
(__)The text establishes as a demonstrated causal fact that faster aging of male blood and brain tissues explains the difference in life expectancy between men and women.
(__)Lifestyle practices such as physical activity, adequate sleep and not smoking are presented as supported by stronger evidence than the newer medications discussed.
(__)The expression "bench to bedside" describes a movement from clinical observations toward laboratory research without direct application to patient care.
The correct sequence, from top to bottom, is:
Based on the text, judge the statements below as True (T) or False (F):
(__)The epigenetic clock is presented as one useful measure of biological aging rather than as a complete explanation of longevity.
(__)The text establishes as a demonstrated causal fact that faster aging of male blood and brain tissues explains the difference in life expectancy between men and women.
(__)Lifestyle practices such as physical activity, adequate sleep and not smoking are presented as supported by stronger evidence than the newer medications discussed.
(__)The expression "bench to bedside" describes a movement from clinical observations toward laboratory research without direct application to patient care.
The correct sequence, from top to bottom, is:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392983
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
A public-school teacher uses the article to design tasks
that require different reading strategies, from locating
information to examining how scientific claims are framed
and supported.
Judge the statements below as True (T) or False (F):
(__)Reading the title, section headings and opening paragraphs rapidly to identify the article's general focus is consistent with skimming.
(__)Searching the article specifically for figures such as "13,000 DNA samples", "58" and "11 divisions" is an example of scanning.
(__)Concluding that the article proves newer medications extend human lifespan is a valid inference because the expression "show promise" presents their effectiveness as established.
(__)Examining how the institutional source presents UCLA's research achievements and comparing promotional framing with the strength of the evidence is compatible with critical literacy.
The correct sequence, from top to bottom, is:
Judge the statements below as True (T) or False (F):
(__)Reading the title, section headings and opening paragraphs rapidly to identify the article's general focus is consistent with skimming.
(__)Searching the article specifically for figures such as "13,000 DNA samples", "58" and "11 divisions" is an example of scanning.
(__)Concluding that the article proves newer medications extend human lifespan is a valid inference because the expression "show promise" presents their effectiveness as established.
(__)Examining how the institutional source presents UCLA's research achievements and comparing promotional framing with the strength of the evidence is compatible with critical literacy.
The correct sequence, from top to bottom, is:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392984
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
The article combines tense, voice and modality to
distinguish current relevance, research findings and
degrees of epistemic certainty. Consider the grammatical
choices made in the excerpts below.
Analyze the statements:
I.In "Dr. Horvath's epigenetic clocks have become standard tools across aging research", the Present Perfect relates a development originating in the past to a current state.
II.In "People whose epigenetic age was higher [...] were shown to be at an increased risk", the passive construction foregrounds the research finding rather than the researchers responsible for demonstrating it.
III.In "which might be the reason women live longer", the modal verb might presents the proposed explanation as a conclusion regarded by the writer as highly certain.
It is correct to state that:
Analyze the statements:
I.In "Dr. Horvath's epigenetic clocks have become standard tools across aging research", the Present Perfect relates a development originating in the past to a current state.
II.In "People whose epigenetic age was higher [...] were shown to be at an increased risk", the passive construction foregrounds the research finding rather than the researchers responsible for demonstrating it.
III.In "which might be the reason women live longer", the modal verb might presents the proposed explanation as a conclusion regarded by the writer as highly certain.
It is correct to state that:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392986
Inglês
Texto associado
O texto seguinte servirá de base para responder à questão.
A leader in the study of longevity is returning to
UCLA Health
Renowned geroscientist and computational biologist
Steve Horvath, PhD, is returning as a professor in the
David Geffen School of Medicine at UCLA on July 1, after
4 1/2 years in the biotech industry. Previously, he was a
full-time professor of Human Genetics and Biostatistics at
UCLA for 22 years.
Geroscience is the modern term for the biology of aging.
Dr. Horvath, who was born in Germany, is internationally
known for his research into the aging process and, in
particular, epigenetics, how the environment influences
our genes, affecting a person's longevity.
His groundbreaking research, which he began at UCLA in
2011, looked at the "epigenetic age" of more than 13,000
DNA samples of people from the U.S. and Europe,
determined from the chemical modifications of their DNA
(also called DNA methylation).
People whose epigenetic age was higher than their
chronological age were shown to be at an increased risk
of death from all causes. From this, Dr. Horvath
developed the "epigenetic clock," a way of measuring
biological aging and mortality risk.
"The universal mammalian methylation clock was really a
UCLA triumph — a true team effort," said Dr. Horvath,
who received the 2026 Luminary Award at the Precision
Medicine World Conference. That project, part of the
international Mammalian Methylation Consortium that Dr.
Horvath led, drew on collaborators across UCLA,
including Jason Ernst, PhD; William Yang, MD, PhD;
Ebru Erbay, MD, PhD; Karen Sears, PhD; and Ren
Larison, PhD.
Aging is a growing field of study and the Division of
Geriatrics is a research leader.
"Aging happens at the cellular level — every tissue in the
human body shows signs of aging," explained Arun S.
Karlamangla, MD, PhD, chief of the UCLA Division of
Geriatrics. "The epigenetic profile is affected by stresses
in life. As we age, these stresses change DNA
functionality. Dr. Horvath's research showed that these
changes can be quantified and used to predict a person's
lifespan."
None of us has control over the DNA we're born with, but
we do have some control over how long we live.
"The epigenetic clock is one window into biological aging,
but it doesn't capture everything, and plenty of
well-established factors influence how long and how well
a person lives," said Dr. Horvath. "The strongest
evidence is for the basics: not smoking, maintaining a
healthy weight, a sensible diet, regular physical activity
and good sleep."
Dr. Horvath has run the test on himself and by the
epigenetic clock, he is about three years younger than
his chronological age of 58.
New medications also show promise for improving
longevity, he said. "There's active research interest in
newer GLP-1 receptor agonists — e.g., the
Ozempic/Wegovy class — which are reshaping how we
think about metabolic health," said Dr. Horvath, adding
that the same is true for anti-inflammatory and antifibrotic
drugs.
Dr. Horvath's epigenetic clocks have become standard
tools across aging research, used by teams worldwide to
test what actually changes biological aging.
They have been applied in the randomized DO-HEALTH
trial, where omega-3, vitamin D and exercise modestly
slowed epigenetic aging in adults older than 70; in the
Women's Health Initiative, where faster epigenetic aging
tracked with later cognitive impairment and dementia;
and in studies of cardiovascular disease and mortality.
This kind of population-level application aligns closely
with the Division of Geriatrics' emphasis on healthy,
independent life expectancy.
Dr. Horvath's research has also shown that the cells of
different organs age at different rates. For instance, the
liver ages faster than other organs, he said, particularly in
the case of people with obesity.
Another discovery was that the blood and brain tissues of
human males age faster than those of females, which
might be the reason women live longer on average than
men across all cultures and countries.
Leading in aging research
The study of aging at the UCLA Division of Geriatrics
focuses on understanding the epidemiology of
age-related conditions such as frailty, cognitive
impairment and dementia, and improving the delivery of
compassionate, comprehensive care to older adults.
Dr. Horvath's return to UCLA will bolster the department's
role in aging research by translating his cellular research
to clinical trials, said Dr. Karlamangla.
"We want to be pioneers in all three aspects: cellular
research, clinical and population-level research, and
health services and implementation research," Dr.
Karlamangla said. "We are one of the pioneers in clinical
innovation for the delivery of healthcare to older adults,"
he said, an approach that is called bench to bedside.
Life expectancy is important, but even more important is
good health, which is necessary for independence, Dr.
Karlamangla emphasized. This is referred to as healthy
life expectancy, or independent life expectancy.
New work at UCLA
Along with serving as a professor, Dr. Horvath will return
to UCLA Health as director of aging biology research in
the Department of Medicine, working across 11 divisions.
In this way, he will work directly with doctors to apply
aging research to their patients. The move into the
Department of Medicine is deliberate: his focus now is translating discoveries from aging biology into care for
patients.
"What I'm most looking forward to in returning to UCLA is
the people and the collaborative environment," said Dr.
Horvath. "UCLA has remarkable strength across
medicine, computational biology, stem cell biology, and
the basic science of complex diseases, and being back in
that setting with former colleagues and future students is
what excites me most.
"It feels like the right place to do the next phase of this
work: helping to translate findings from aging biology into
the clinic."
https://www.uclahealth.org/news/article/leader-study-longevity-returning
-ucla-health
A public-school English teacher uses the UCLA Health
article to design a sequence of reading tasks. In the first
stage, students identify explicit information about Dr.
Horvath's career and research. In the second, they
distinguish established evidence from tentative claims by
examining expressions such as "show promise" and
"might be the reason". In the final stage, they produce a
clear summary of the article, selecting relevant evidence
and preserving the degree of certainty expressed in the
original text.
Considering the CEFR (Common European Framework of Reference for Languages) as a framework for progression in communicative language ability, select the correct alternative.
Considering the CEFR (Common European Framework of Reference for Languages) as a framework for progression in communicative language ability, select the correct alternative.
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392987
Inglês
In natural spoken English, words are not necessarily
pronounced in exactly the same way as when they are
produced in isolation. Connected speech may involve
changes related to linking, sound omission, stress
placement and the interaction between adjacent sounds.
Judge the statements below as True (T) or False (F):
(__)In a non-rhotic variety of British English, the final letter r in far is normally silent when the word occurs alone, but the corresponding sound may be pronounced in far away because the following word begins with a vowel.
(__)In rapid speech, the t sound in next day may be omitted because of the complex consonant sequence, illustrating elision rather than the addition of a new sound.
(__)In did you, the final sound of did and the initial sound represented by y in you may interact and produce a pronunciation similar to the beginning of the word June.
(__)The words photograph and photography maintain primary stress on the same syllable because words belonging to the same lexical family normally preserve identical stress patterns.
The correct sequence, from top to bottom, is:
Judge the statements below as True (T) or False (F):
(__)In a non-rhotic variety of British English, the final letter r in far is normally silent when the word occurs alone, but the corresponding sound may be pronounced in far away because the following word begins with a vowel.
(__)In rapid speech, the t sound in next day may be omitted because of the complex consonant sequence, illustrating elision rather than the addition of a new sound.
(__)In did you, the final sound of did and the initial sound represented by y in you may interact and produce a pronunciation similar to the beginning of the word June.
(__)The words photograph and photography maintain primary stress on the same syllable because words belonging to the same lexical family normally preserve identical stress patterns.
The correct sequence, from top to bottom, is:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392988
Inglês
An English teacher notices that advanced students
frequently produce grammatically possible sentences that
sound non-idiomatic because they combine words in
unusual ways. The teacher decides to redesign part of
the course according to principles associated with the
Lexical Approach.
Select the classroom practice that is most consistent with this approach.
Select the classroom practice that is most consistent with this approach.
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392989
Inglês
Connected speech may involve phonological processes
that are not evident from the orthographic form of isolated
words. Consider common descriptions of English
pronunciation in fluent speech.
Judge the statements below as True (T) or False (F):
(__)In a non-rhotic accent, far away may contain a linking /r/ even though word-final /r/ would not normally be pronounced before a pause.
(__)In ten people, /n/ may be realized with a bilabial place of articulation before /p/, illustrating anticipatory assimilation.
(__)When /t/ is omitted from a cluster in a rapid pronunciation of next day, the process is properly classified as epenthesis.
(__)In connected speech, the sequence /d/ + /j/ in would you may undergo coalescence and be realized with a sound resembling /dʒ/.
The correct sequence, from top to bottom, is:
Judge the statements below as True (T) or False (F):
(__)In a non-rhotic accent, far away may contain a linking /r/ even though word-final /r/ would not normally be pronounced before a pause.
(__)In ten people, /n/ may be realized with a bilabial place of articulation before /p/, illustrating anticipatory assimilation.
(__)When /t/ is omitted from a cluster in a rapid pronunciation of next day, the process is properly classified as epenthesis.
(__)In connected speech, the sequence /d/ + /j/ in would you may undergo coalescence and be realized with a sound resembling /dʒ/.
The correct sequence, from top to bottom, is:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392991
Inglês
Advanced grammatical competence requires recognizing
syntactic relationships that remain equivalent even when
surface structures differ.
Analyze the statements below:
I.Had the committee known about the procedural error, it would have postponed the vote is an inverted third conditional corresponding to If the committee had known about the procedural error....
II.She asked where did the students go preserves the appropriate word order of an indirect interrogative clause in standard English.
III.If he had accepted the position, he would be working here now combines a counterfactual past condition with a hypothetical present consequence.
It is correct to state that:
Analyze the statements below:
I.Had the committee known about the procedural error, it would have postponed the vote is an inverted third conditional corresponding to If the committee had known about the procedural error....
II.She asked where did the students go preserves the appropriate word order of an indirect interrogative clause in standard English.
III.If he had accepted the position, he would be working here now combines a counterfactual past condition with a hypothetical present consequence.
It is correct to state that:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392996
Inglês
The treatment of English as a lingua franca in the BNCC
affects both the understanding of linguistic variation and
the relationship among the different dimensions of
language learning.
Analyze the statements below:
I.Treating English as a lingua franca challenges the idea that legitimate use of the language belongs exclusively to speakers from particular national territories.
II.Linguistic knowledge should be mastered before oral, reading and writing practices, since the BNCC treats grammatical knowledge as a prerequisite for meaningful language use.
III.The intercultural dimension includes reflection on relations among language, identity and culture and on the social effects associated with the global circulation of English.
It is correct to state that:
Analyze the statements below:
I.Treating English as a lingua franca challenges the idea that legitimate use of the language belongs exclusively to speakers from particular national territories.
II.Linguistic knowledge should be mastered before oral, reading and writing practices, since the BNCC treats grammatical knowledge as a prerequisite for meaningful language use.
III.The intercultural dimension includes reflection on relations among language, identity and culture and on the social effects associated with the global circulation of English.
It is correct to state that:
Ano: 2026
Banca:
AMEOSC
Órgão:
Prefeitura de Barra Bonita - SC
Prova:
AMEOSC - 2026 - Prefeitura de Barra Bonita - SC - Professor II (Língua Estrangeira – Inglês) |
Q4392997
Inglês
Read the study case:
A public-school English teacher wants to work within Communicative Language Teaching but rejects the idea that communicative teaching requires the complete exclusion of explicit attention to linguistic form. The class objective is to develop students' ability to negotiate information while maintaining sufficient accuracy for successful communication.
Considering Communicative Language Teaching (CLT), select the correct pedagogical arrangement.
A public-school English teacher wants to work within Communicative Language Teaching but rejects the idea that communicative teaching requires the complete exclusion of explicit attention to linguistic form. The class objective is to develop students' ability to negotiate information while maintaining sufficient accuracy for successful communication.
Considering Communicative Language Teaching (CLT), select the correct pedagogical arrangement.
Conheça nossos planos